MAIA Biotechnology, Inc.
MAIANYSEAMERICANHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $67.48M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.87$3.19
- Volume (live)
- -
- Avg. volume (3M)
- 550.38K
MAIA Biotechnology (MAIA) Stock Price & Financial Analysis
MAIA Biotechnology Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.11 - $1.15 |
|---|---|
| 52-Week High | $3.19 |
| 52-Week Low | $0.87 |
| Open | $1.15 |
| Volume (last close) | 279.98K |
| Average Volume (3M) | 550.38K |
| 50-Day MA | $1.28 |
|---|---|
| 200-Day MA | $1.48 |
| 1-Year Change | −22.60% |
| Market Cap | 67.48M |
|---|---|
| Shares Outstanding | 60.79M |
| Price to Book (P/B) | 3.26 |
| EV/EBITDA | -1.55 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
MAIA Biotechnology at a Glance
As of the Oct 26, 2026 close, MAIA Biotechnology (MAIA) has a market capitalization of $67.48M.
As of its latest reported balance sheet, it holds $27.60M in cash and securities against $0.00 of debt, a net cash position of $27.60M.
MAIA Biotechnology does not currently pay a dividend.
The share price is down 22.6% over the past year. At $1.11 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $0.87 to $3.19, below its 200-day moving average of $1.48.
Frequently Asked Questions About MAIA Biotechnology
What is the current stock price for MAIA?
As of the Oct 26, 2026 close, MAIA stock trades at $1.11. The 52-week range is $0.87–$3.19, with a day range of $1.11–$1.15.
What is the P/E ratio for MAIA?
The P/E ratio (Price-to-Earnings) for MAIA is shown in the Key Statistics section. This valuation metric helps compare MAIA Biotechnology, Inc. to industry peers.
Does MAIA pay dividends?
MAIA Biotechnology does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MAIA?
Analyst ratings and recommendations for MAIA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of MAIA?
As of the Oct 26, 2026 close, MAIA Biotechnology's market capitalization is $67.5M, classifying it as a micro-cap company. MAIA Biotechnology operates in the Healthcare sector within the Biotechnology industry.